Dr. Reddy's Laboratories Ltd. maintained that it’s been business as usual in Russia amid the Ukraine conflict, with no concerns around repatriation of dues, at least for now, while also signaling momentum in China, another market where the Indian company has had a long-standing presence. (See side box)
Dr Reddy’s Pressing On In Russia, China Approvals Add Spark
Sputnik Light Being Pursued As Universal Booster
Momentum for Dr Reddy’s in China as a string of approvals including for lenalidomide come through, while it appears to be on an even keel in Russia, a market where several foreign firms have cutback activities in the wake of the Ukraine conflict. Will the Indian firm’s Russia strategy payback?
